Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma

por Udhrain, Ashish, Skubitz, Keith M, Northfelt, Donald W
Publicado 2007

Intersection of Cardiology and Oncology Clinical Practices

por Mookadam, Farouk, Sharma, Ashwini, Lee, Howard R., Northfelt, Donald W.
Publicado 2014

Factitious Disorder in Crohn's Disease: Recurrent Pancytopenia Caused by Surreptitious Ingestion of 6-Mercaptopurine

por Kahn, Allon, Boroff, Erika S., Martin, Kari A., Northfelt, Donald W., Heigh, Russell I.
Publicado 2015

Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report

por Schuster, Steven R., Pockaj, Barbara A., Bothe, Mary R., David, Paru S., Northfelt, Donald W.
Publicado 2012

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer

por Sparano, Joseph A., O’Neill, Anne, Graham, Noah, Northfelt, Donald W., Dang, Chau T., Wolff, Antonio C., Sledge, George W., Miller, Kathy D.
Publicado 2022

Understanding American Indian Perceptions Toward Radiation Therapy

por Patel, Samir H., Ebrahimi, Sasha, Northfelt, Donald W., Mathews, Timothy E., Omar, Farhia M., Martinez, Erika D., DeWees, Todd A., Okamoto, Janet M.
Publicado 2020

Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer

por Rosenberg, Shoshana M., O’Neill, Anne, Sepucha, Karen, Miller, Kathy D., Dang, Chau T., Northfelt, Donald W., Sledge, George W., Schneider, Bryan P., Partridge, Ann H.
Publicado 2022

Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors

por Curtis, Kelly K., Sarantopoulos, John, Northfelt, Donald W., Weiss, Glen J., Barnhart, Kerry M., Whisnant, John K., Leuschner, Carola, Alila, Hector, Borad, Mitesh J., Ramanathan, Ramesh K.
Publicado 2014

Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase

por Sachdev, Jasgit C., Munster, Pamela, Northfelt, Donald W., Han, Hyo Sook, Ma, Cynthia, Maxwell, Fiona, Wang, Tiffany, Belanger, Bruce, Zhang, Bin, Moore, Yan, Thiagalingam, Arunthathi, Anders, Carey
Publicado 2020

Choosing wisely after publication of level I evidence in breast cancer radiotherapy

por Niska, Joshua R, Keole, Sameer R, Pockaj, Barbara A, Halyard, Michele Y, Patel, Samir H, Northfelt, Donald W, Gray, Richard J, Wasif, Nabil, Vargas, Carlos E, Wong, William W
Publicado 2018

Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin

por Costello, Collin M., Maly, Connor J., Snider, Sam, Severson, Kevin J., DiCaudo, David J., Rosenthal, Allison C., Northfelt, Donald W., Rule, William, Craig, Fiona E., Pittelkow, Mark R., Mangold, Aaron R.
Publicado 2019

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

por Barrett, Michael T., Anderson, Karen S., Lenkiewicz, Elizabeth, Andreozzi, Mariacarla, Cunliffe, Heather E., Klassen, Christine L., Dueck, Amylou C., McCullough, Ann E., Reddy, Srikanth K., Ramanathan, Ramesh K., Northfelt, Donald W., Pockaj, Barbara A.
Publicado 2015

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

por Bagegni, Nusayba, Thomas, Shana, Liu, Ning, Luo, Jingqin, Hoog, Jeremy, Northfelt, Donald W., Goetz, Matthew P., Forero, Andres, Bergqvist, Mattias, Karen, Jakob, Neumüller, Magnus, Suh, Edward M., Guo, Zhanfang, Vij, Kiran, Sanati, Souzan, Ellis, Matthew, Ma, Cynthia X.
Publicado 2017

Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors

por Tang, Xiaojia, Thompson, Kevin J., Kalari, Krishna R., Sinnwell, Jason P., Suman, Vera J., Vedell, Peter T., McLaughlin, Sarah A., Northfelt, Donald W., Aspitia, Alvaro Moreno, Gray, Richard J., Carter, Jodi M., Weinshilboum, Richard, Wang, Liewei, Boughey, Judy C., Goetz, Matthew P.
Publicado 2023

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

por Ademuyiwa, Foluso O., Northfelt, Donald W., O’Connor, Tracey, Levine, Ellis, Luo, Jingqin, Tao, Yu, Hoog, Jeremy, Laury, Marie L., Summa, Tracy, Hammerschmidt, Trish, Guo, Zhanfang, Frith, Ashley, Weilbaecher, Katherine, Opyrchal, Mateusz, Aft, Rebecca, Clifton, Katherine, Suresh, Rama, Bagegni, Nusayba, Hagemann, Ian S., Iglesia, Michael D., Ma, Cynthia X.
Publicado 2023

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome‐Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

por Dudenkov, Tanda M., Liu, Duan, Cairns, Junmei, Devarajan, Sandhya, Zhuang, Yongxian, Ingle, James N., Buzdar, Aman U., Robson, Mark E., Kubo, Michiaki, Batzler, Anthony, Barman, Poulami, Jenkins, Gregory D., Carlson, Erin E., Goetz, Matthew P., Northfelt, Donald W., Moreno‐Aspitia, Alvaro, Desta, Zeruesenay, Reid, Joel M., Kalari, Krishna R., Wang, Liewei, Weinshilboum, Richard M.
Publicado 2019

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

por Goetz, Matthew P., Kalari, Krishna R., Suman, Vera J., Moyer, Ann M., Yu, Jia, Visscher, Daniel W., Dockter, Travis J., Vedell, Peter T., Sinnwell, Jason P., Tang, Xiaojia, Thompson, Kevin J., McLaughlin, Sarah A., Moreno-Aspitia, Alvaro, Copland, John A, Northfelt, Donald W., Gray, Richard J., Hunt, Katie, Conners, Amy, Weinshilboum, Richard, Wang, Liewei, Boughey, Judy C.
Publicado 2017

Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial

por Pierobon, Mariaelena, Robert, Nicholas J., Northfelt, Donald W., Jahanzeb, Mohammad, Wong, Shukmei, Hodge, Kimberly A., Baldelli, Elisa, Aldrich, Jessica, Craig, David W., Liotta, Lance A., Avramovic, Sanja, Wojtusiak, Janusz, Alemi, Farrokh, Wulfkuhle, Julia D., Bellos, Angela, Gallagher, Rosa I., Arguello, David, Conrad, Amber, Kemkes, Ariane, Loesch, David M., Vocila, Linda, Dunetz, Bryant, Carpten, John D., Petricoin, Emanuel F., Anthony, Stephen P.
Publicado 2021

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

por Ademuyiwa, Foluso O., Gao, Feng, Street, Cherease R., Chen, Ina, Northfelt, Donald W., Wesolowski, Robert, Arora, Mili, Brufsky, Adam, Dees, E. Claire, Santa-Maria, Cesar A., Connolly, Roisin M., Force, Jeremy, Moreno-Aspitia, Alvaro, Herndon, John M., Carmody, Madelyn, Davies, Sherri R., Larson, Sarah, Pfaff, Kathleen L., Jones, Stephanie M., Weirather, Jason L., Giobbie-Hurder, Anita, Rodig, Scott J., Liu, Zheng, Hagemann, Ian S., Sharon, Elad, Gillanders, William E.
Publicado 2022

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

por Ellingson, Marissa S., Hart, Steven N., Kalari, Krishna R., Suman, Vera, Schahl, Kimberly A., Dockter, Travis J., Felten, Sara J., Sinnwell, Jason P., Thompson, Kevin J., Tang, Xiaojia, Vedell, Peter T., Barman, Poulami, Sicotte, Hugues, Eckel-Passow, Jeanette E., Northfelt, Donald W., Gray, Richard J., McLaughlin, Sarah A., Moreno-Aspitia, Alvaro, Ingle, James N., Moyer, Ann M., Visscher, Daniel W., Jones, Katie, Conners, Amy, McDonough, Michelle, Wieben, Eric D., Wang, Liewei, Weinshilboum, Richard, Boughey, Judy C., Goetz, Matthew P.
Publicado 2015